Oncology BAA Awards Estimated

Past New Requirement Updated

Agency
Solicitation expected
Estimated value
$700,000 to $1,500,000
Set-aside
No set-aside

Forecast facts

Anticipated award
NAICS code
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Points of contact

Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.

About this forecast

The Department of Health and Human Services Food and Drug Administration (FDA) is forecasting a new contract opportunity through the Oncology Center of Excellence's (OCE's) Scientific Collaborative Program, focusing on research and development in oncology and drug development. The contract, classified under NAICS 541715 for research and development in physical, engineering, and life sciences, is estimated to have a solicitation release date of March 1, 2026, with an anticipated award date of May 1, 2026. This opportunity aims to support groundbreaking research efforts that contribute to the FDA's public health mission.

While specific award values and budget ranges are not currently available, the contract appears to be centered on supporting oncology research and development initiatives. Potential contractors should note the key points of contact are Joshua Holliday (joshua.holliday@fda.hhs.gov) and a generic FDA email (tbd@fda.gov). The procurement is not set aside for any specific type of business, indicating it may be open to a wide range of qualified research and development organizations with expertise in oncology and pharmaceutical development.

Forecast text

The Oncology Center of Excellence's (OCE's) Scientific Collaborative Program has led the way in supporting groundbreaking research efforts in oncology and drug development, contributing greatly to the FDA public health mission.

On GovTribe

Work this forecast

  • Track it in your pipeline
  • Find teaming partners
  • Similar forecasts
  • Ask GovTribe AI about this forecast